Cargando…
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting
Autores principales: | Graham, Maryza, Muhi, Stephen, Hoang, Tuyet, Ballard, Susan A., McAuley, Julie, Kwong, Jason C., Williamson, Deborah A., Howden, Benjamin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416649/ https://www.ncbi.nlm.nih.gov/pubmed/34561096 http://dx.doi.org/10.1016/j.pathol.2021.07.002 |
Ejemplares similares
-
Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023) -
Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023) -
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
por: Muhi, Stephen, et al.
Publicado: (2021) -
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021) -
Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)